Regulatory Affairs Services Provider in Denmark
Denmark offers a highly structured and innovation-driven pharmaceutical market within the European Union, supported by strong regulatory systems, advanced healthcare infrastructure, and early adoption of new therapies. While market access is predictable, it is governed by strict EU legislation, national authority requirements, and a clearly defined pricing and reimbursement framework.
Successful entry into Denmark requires alignment with European Medicines Agency procedures, Danish Medicines Agency expectations, and national market access pathways.
DDReg provides specialized Regulatory Affairs Services in Denmark, supporting pharmaceutical companies with compliant submissions, efficient approvals, and end-to-end regulatory execution across EU and national frameworks.
Regulatory Affairs Services in Denmark
Pharmaceutical regulation in Denmark is overseen by the Danish Medicines Agency (DHMA).
- Evaluation and authorization of medicinal products through national procedures
- Participation in EU regulatory procedures (centralized, decentralized, and mutual recognition)
- Pharmacovigilance and safety monitoring
- Clinical trial authorization and oversight
- Inspection of manufacturing, distribution, and GxP compliance
Denmark operates fully within the European Union regulatory system, with strong integration into EMA-led processes.
Our Expert Regulatory Affairs Services in Denmark
- Regulatory strategy and EU pathway selection (centralized, DCP, MRP, national)
- Product registration and marketing authorization support
- CTD/eCTD dossier preparation, publishing, and validation
- Dossier gap analysis aligned with DHMA and EMA requirements
- Submission planning and lifecycle coordination
- Regulatory query management and authority interaction
- Pricing and reimbursement support aligned with Danish processes
- Local regulatory coordination and MAH support within the EU
- Lifecycle management including variations, renewals, and updates
- Labeling and artwork compliance (EU + Danish requirements)
- Regulatory intelligence and ongoing compliance monitoring
Our approach focuses on submission quality, regulatory precision, and efficient execution.
Regulatory Affairs Process in Denmark
Market access in Denmark depends on approval through the appropriate EU or national regulatory pathway
Applications are submitted in eCTD format and evaluated either:
- Centrally via the European Medicines Agency (EMA)
- Through decentralized, mutual recognition, or national procedures involving the Danish Medicines Agency
Following regulatory approval, pricing and reimbursement decisions are managed at the national level and are essential for commercial access.
Regulatory success depends on accurate pathway selection, dossier completeness, and alignment with both EU and Danish requirements.
Why Choose DDReg for Regulatory Affairs Services in Denmark ?
DDReg brings a structured and execution-focused approach to Regulatory Affairs Consulting in Denmark, ensuring consistency across EU and national regulatory processes.
- Strong understanding of DHMA and EU regulatory frameworks
- Experience across centralized, decentralized, and national procedures
- Focus on submission-ready, compliant dossiers
- Integrated support across regulatory and market access pathways
- End-to-end lifecycle management capabilities
This ensures efficient progression from regulatory strategy to approval and post-approval compliance.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Denmark portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
